Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,904 | -36,529 | -27,616 | -18,741 | -5,052 |
| Depreciation Amortization | 930 | 3,631 | 2,698 | 1,801 | 878 |
| Accounts receivable | 1,270 | 3,891 | 2,810 | 2,049 | -1,654 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | N/A | 2,561 |
| Other Working Capital | -1,366 | 7,929 | 6,957 | 7,604 | -153 |
| Other Operating Activity | -1,211 | -2,492 | -1,807 | -1,524 | -568 |
| Operating Cash Flow | $-6,281 | $-23,570 | $-16,958 | $-8,811 | $-3,988 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -810 | -5,703 | -4,999 | -4,016 | -2,604 |
| Other Investing Activity | -42 | -165 | -122 | -77 | -46 |
| Investing Cash Flow | $-852 | $-5,868 | $-5,121 | $-4,093 | $-2,650 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 25,574 | 20,927 | 20,913 | 20,909 | 20,936 |
| Financing Cash Flow | $25,574 | $20,927 | $20,913 | $20,909 | $20,936 |
| Exchange Rate Effect | 163 | -388 | -170 | 149 | 29 |
| Beginning Cash Position | 27,001 | 35,900 | 35,900 | 35,900 | 35,900 |
| End Cash Position | 45,605 | 27,001 | 34,564 | 44,054 | 50,227 |
| Net Cash Flow | $18,604 | $-8,899 | $-1,336 | $8,154 | $14,327 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,281 | -23,570 | -16,958 | -8,811 | -3,988 |
| Capital Expenditure | -810 | -5,705 | -5,001 | -4,016 | -2,604 |
| Free Cash Flow | -7,091 | -29,275 | -21,959 | -12,827 | -6,592 |